Supreme Court Rejects Certiorari Bid In Dispute Over Patent Indefiniteness
WASHINGTON, D.C. — In its Nov. 2 orders list, the U.S. Supreme Court turned away a request by a brand-name drug maker for review of a divided 2019 Federal Circuit U.S....To view the full article, register now.
Already a subscriber? Click here to view full article